Sophia Genetics SA

NASDAQ SOPH

Download Data

Sophia Genetics SA Revenue Per Share for the year ending December 31, 2023: USD 0.96

Sophia Genetics SA Revenue Per Share is USD 0.96 for the year ending December 31, 2023, a 29.82% change year over year. Revenue per share measures the amount of revenue generated by a company per outstanding share. It is calculated by dividing the revenue by the number of outstanding shares (weighted average). This ratio provides insights into the company's revenue generation on a per-share basis. A higher revenue per share indicates stronger revenue performance and potentially higher value per share for investors.
  • Sophia Genetics SA Revenue Per Share for the year ending December 31, 2022 was USD 0.74, a 17.13% change year over year.
  • Sophia Genetics SA Revenue Per Share for the year ending December 31, 2021 was USD 0.63, a 42.43% change year over year.
  • Sophia Genetics SA Revenue Per Share for the year ending December 31, 2020 was USD 0.44, a -15.79% change year over year.
  • Sophia Genetics SA Revenue Per Share for the year ending December 31, 2019 was USD 0.53.
NASDAQ: SOPH

Sophia Genetics SA

CEO Dr. Jurgi Camblong M.B.A., Ph.D.
IPO Date July 23, 2021
Location Switzerland
Headquarters Rue du Centre 172, Saint-Sulpice, Switzerland, 1025
Employees 430
Sector Healthcare
Industry Health information services
Description

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Similar companies

FORA

Forian Inc

USD 2.84

9.65%

MDRX

Veradigm Inc.

USD 9.60

1.05%

SLP

Simulations Plus Inc

USD 45.99

-4.66%

PINC

Premier Inc

USD 19.09

0.90%

StockViz Staff

September 8, 2024

Any question? Send us an email